Back to Archived Journals » Gastrointestinal Cancer: Targets and Therapy » Volume 7

Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer

Total article views   HTML views PDF downloads Totals
11,289 Dovepress* 11,289+ 729 12,018
Totals 11,289 729 12,018
*Since 1 December 2017

View citations on Google Scholar